How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,161 results for

Hypertrichosis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Hirsutism (Overview)

Hirsutism (Overview) Hirsutism: Practice Essentials, Pathophysiology, Epidemiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTIxMDM4LW92ZXJ2aWV3 processing > Hirsutism Updated: Apr 13, 2018 Author: George T (...) Griffing, MD; Chief Editor: Michel E Rivlin, MD Share Email Print Feedback Close Sections Sections Hirsutism Overview Practice Essentials Although hirsutism is broadly defined as excessive hairiness, the common clinical use of the term refers to women with excess growth of terminal hair in a male pattern. In this sense, hirsutism is one of the most common endocrine disorders, affecting approximately 10% of women in the United States. In these women, the hairiness implies the presence of abnormal

2014 eMedicine.com

62. Hirsutism (Follow-up)

be combined with laser treatments for enhanced effects. [ ] Metformin (Glucophage) reduces insulin levels, and this change, in turn, reduces the ovarian testosterone levels by competitive inhibition of the ovarian insulin receptors. This drug is effective in treating hirsutism in women with PCOS. Management depends on the underlying cause. For example, non–androgen-dependent excess hair, such as hypertrichosis, is treated primarily with physical hair removal methods. In contrast, patients with androgen (...) Hirsutism (Follow-up) Dermatologic Manifestations of Hirsutism Treatment & Management: Medical Care, Surgical Care, Diet Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA3MjAzMS10cmVhdG1lbnQ= processing

2014 eMedicine.com

63. Hirsutism (Follow-up)

Hirsutism (Follow-up) Hirsutism Treatment & Management: Medical Care Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTIxMDM4LXRyZWF0bWVudA== processing > Hirsutism Treatment & Management Updated: Apr 13, 2018 (...) Author: George T Griffing, MD; Chief Editor: Michel E Rivlin, MD Share Email Print Feedback Close Sections Sections Hirsutism Treatment Medical Care The treatment of hirsutism begins with a careful explanation about the cause of the problem and reassurance that the patient is not losing her femininity. Then, direct intervention, if possible, is instituted for the underlying disorder. If hirsutism persists (or the patient has idiopathic hirsutism), other cosmetic or systemic treatment may be necessary

2014 eMedicine.com

64. Acquired Localized Hypertrichosis Induced by Rivastigmine Full Text available with Trip Pro

Acquired Localized Hypertrichosis Induced by Rivastigmine Hypertrichosis is the excessive hair growth in any area of the skin surface. Acquired localized hypertrichosis may be secondary to multiple causes and there is a secondary form due to several drugs, which is usually reversible with discontinuation of the causative agent. Rivastigmine is a reversible and competitive inhibitor of acetylcholinesterase and butyrylcholinesterase used for symptomatic treatment of Alzheimer dementia (...) and Parkinson's disease. It has an adequate safety profile and cutaneous side effects are unusual. Irritant contact dermatitis, allergic dermatitis, baboon syndrome, and cutaneous rash due to rivastigmine have been reported. We report on a Caucasian 80-year-old male with personal history of Alzheimer's disease. The patient started therapy with oral rivastigmine one month prior to clinical presentation of localized hypertrichosis on both forearms. Norgalanthamine has been shown to promote hair growth activity

2016 Case reports in dermatological medicine

65. Anterior cervical hypertrichosis: a sporadic case Full Text available with Trip Pro

Anterior cervical hypertrichosis: a sporadic case Anterior cervical hypertrichosis is a very rare form of primary localized hypertrichosis. It consists of a tuft of terminal hair on the anterior neck just above the laryngeal prominence. The etiology is still unknown. In this article, we reported a 15-year-old female patient who presented to our clinic with a complaint of hypertrichosis on the anterior aspect of the neck for the last five years. Her past medical history revealed no pathology (...) except for vesicoureteral reflux. On the basis of clinical presentation, our patient was diagnosed with anterior cervical hypertrichosis and she was considered to be a sporadic case due to lack of other similar cases in familial history. To date, 33 patients with anterior cervical hypertrichosis have been reported. Anterior cervical hypertrichosis can be associated with other abnormalities, but it frequently presents as an isolated defect (70%). The association of vesicoureteral reflux and anterior

2016 Turkish Archives of Pediatrics/Türk Pediatri Arşivi

66. Hirsutism in a Female Adolescent Induced by Long-Acting Injectable Risperidone: A Case Report Full Text available with Trip Pro

Hirsutism in a Female Adolescent Induced by Long-Acting Injectable Risperidone: A Case Report 24171143 2013 10 30 2018 11 13 2155-7772 15 3 2013 The primary care companion for CNS disorders Prim Care Companion CNS Disord Hirsutism in a female adolescent induced by long-acting injectable risperidone: a case report. 10.4088/PCC.12l01454 PCC.12l01454 Patel Ankit A Department of Psychiatry, University of South Alabama, Mobile (Drs Patel, Haq, Turnbow, and Raza and Ms Malek). Malek Naaz N Haq Fasiha

2013 The Primary Care Companion for CNS Disorders

67. Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism

Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies (...) before adding more. Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01817894 Recruitment Status : Completed First Posted : March 26, 2013 Last Update Posted : December 2, 2013 Sponsor: Bispebjerg Hospital

2013 Clinical Trials

68. The impact of self-reported oligo-amenorrhea and hirsutism on fertility and lifetime reproductive success: results from the Northern Finland Birth Cohort 1966. Full Text available with Trip Pro

The impact of self-reported oligo-amenorrhea and hirsutism on fertility and lifetime reproductive success: results from the Northern Finland Birth Cohort 1966. To what extent do self-reported oligo-amenorrhea and hirsutism affect reproductive performance (childlessness, age at first delivery, family size and miscarriage rates)?At the age of 44, among women with both self-reported oligo-amenorrhea and hirsutism the prevalence of childlessness was not significantly different from non-symptomatic (...) women but they had a smaller family size than non-symptomatic women.Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by oligo-amenorrhea or amenorrhea, hyperandrogenism and hirsutism and it is the most frequent cause of anovulatory infertility, but there are few studies on the reproductive capacity of women with PCOS. In our previous population-based cohort study the women with self-reported oligo-amenorrhea and hirsutism were found to have more infertility problems

2013 Human Reproduction

69. Health-Related Quality of Life, Depression and Anxiety Correlate with the Degree of Hirsutism. (Abstract)

Health-Related Quality of Life, Depression and Anxiety Correlate with the Degree of Hirsutism. Hirsutism has a negative impact on women's quality of life. The relation between quality of life, anxiety, depression and the level of hairiness has not been described.To investigate the correlations between the levels of hairiness, quality of life, anxiety and depression.200 patients from Malmö, Örebro and Uppsala, who had been in contact with the clinics for problems with excessive hair growth, were

2013 Dermatology

70. A diagnosis not to be missed: Non-classic steroid 11β-hydroxylase deficiency presenting with premature adrenarche and hirsutism. Full Text available with Trip Pro

A diagnosis not to be missed: Non-classic steroid 11β-hydroxylase deficiency presenting with premature adrenarche and hirsutism. Steroid 11β-hydroxylase (CYP11B1) deficiency (11OHD) is the second most common form of congenital adrenal hyperplasia. Milder nonclassic forms are rare and at risk to be missed.The objective of the study was to demonstrate the challenges in diagnosing nonclassic 11OHD.Patient 1, a 10-year-old boy, presented with high-normal blood pressure and previously unexplained (...) exaggerated adrenarche from age 4 years. Previous tests at the age of 8 years showed normal 17-hydroxyprogesterone concentrations with increased androgens. Patient 2, a 14-year-old female, presented with facial hirsutism, primary amenorrhea, and high-normal blood pressure. Novel CYP11B1 mutations were functionally analyzed in transiently transfected COS7 cells measuring the conversion of 11-deoxycortisol to cortisol by liquid chromatography-tandem mass spectrometry.Biochemical findings including urinary

2013 Journal of Clinical Endocrinology and Metabolism

71. Possible efficacy of Lavender and Tea tree oils in the treatment of young women affected by mild idiopathic hirsutism. (Abstract)

Possible efficacy of Lavender and Tea tree oils in the treatment of young women affected by mild idiopathic hirsutism. Hirsutism is defined as the presence of excessive terminal hair in androgen-dependent areas of a woman's body. Regarding this it has been suggested that Lavender and Tea tree oils may have antiandrogenic activities.To evaluate therapy based on Lavender and Tea tree oils in women suffering from mild idiopathic hirsutism (IH).A prospective, open-label, placebo- controlled (...) , randomized study was performed: women affected by mild IH were randomly assigned to receive oil spray containing Lavender and Tea tree oils (group T) (no. = 12) or placebo (group P) (no. = 12) twice a day for 3 months in areas affected by hirsutism. Evaluation of hirsutism was carried out at baseline and after 3 months by Ferriman-Gallwey score and by measuring hair diameter taken from some body areas. A hematological and hormonal evaluation was carried out at baseline and after 3 months.No significant

2013 Journal of endocrinological investigation Controlled trial quality: uncertain

72. The clinical significance and primary determinants of hirsutism in patients with the polycystic ovary syndrome. Full Text available with Trip Pro

The clinical significance and primary determinants of hirsutism in patients with the polycystic ovary syndrome. Hirsutism is frequently present in patients with polycystic ovary syndrome (PCOS) and is a major sign of hyperandrogenism. However, other disorders frequently present in PCOS, particularly abdominal obesity and insulin resistance (IR), have also been implicated in the development of hirsutism in this population but relevant data are limited. We aimed to define the determinants (...) of the presence of hirsutism in PCOS.Observational study.We studied 1297 patients with PCOS (age 24.3±5.8 years, BMI 26.8±6.9 kg/m(2)). Hirsutism was defined as a modified Ferriman-Gallwey score ≥8.Women with hirsutism were younger, had greater BMI, and had higher levels of circulating androgens than women without hirsutism; markers of IR did not differ between the two groups after adjustment for age and BMI. The prevalence of hirsutism progressively declined with age, was lower in normal-weight women than

2013 European Journal of Endocrinology

73. Hypertrichosis cubiti, a case report and literature review Full Text available with Trip Pro

Hypertrichosis cubiti, a case report and literature review Hypertrichosis cubiti is an uncommon congenital hypertrichosis with links to genetic syndromes, both autosomal dominant and recessive, with variable penetrance and expressivity. It may also present in sporadic cases with no phenotypic abnormalities or family history.

2015 Clinical Case Reports

74. The disruption of a novel limb cis-regulatory element of SHH is associated with autosomal dominant preaxial polydactyly-hypertrichosis. Full Text available with Trip Pro

The disruption of a novel limb cis-regulatory element of SHH is associated with autosomal dominant preaxial polydactyly-hypertrichosis. The expression gradient of the morphogen Sonic Hedgehog (SHH) is crucial in establishing the number and the identity of the digits during anteroposterior patterning of the limb. Its anterior ectopic expression is responsible for preaxial polydactyly (PPD). Most of these malformations are due to the gain-of-function of the Zone of Polarizing Activity Regulatory (...) Sequence, the only limb-specific enhancer of SHH known to date. We report a family affected with a novel condition associating PPD and hypertrichosis of the upper back, following an autosomal dominant mode of inheritance. This phenotype is consistent with deregulation of SHH expression during limb and follicle development. In affected members, we identified a 2 kb deletion located ~240 kb upstream from the SHH promoter. The deleted sequence is capable of repressing the transcriptional activity

2015 European Journal of Human Genetics

75. Congenital Generalized Hypertrichosis, Gingival Hyperplasia, a Coarse Facies with Constriction Bands: A Rare Association Full Text available with Trip Pro

Congenital Generalized Hypertrichosis, Gingival Hyperplasia, a Coarse Facies with Constriction Bands: A Rare Association Congenital generalized hypertrichosis terminalis is a rare primary hypertrichotic condition, of unknown etiology presenting in the pediatric population. Though benign in nature, there is considerable psychosocial trauma attached to this, owing to the cosmetic disfigurement it produces. The association of gingival fibromatosis and a coarse facies could further worsen

2015 International journal of trichology

76. H Syndrome; a Multifaceted Histiocytic Disorder with Hyperpigmentation and Hypertrichosis. Full Text available with Trip Pro

H Syndrome; a Multifaceted Histiocytic Disorder with Hyperpigmentation and Hypertrichosis. 26015165 2016 08 12 2015 11 04 1651-2057 95 8 2015 Nov Acta dermato-venereologica Acta Derm. Venereol. H syndrome: a multifaceted histiocytic disorder with hyperpigmentation and hypertrichosis. 1021-3 10.2340/00015555-2145 Tekin Burak B Department of Dermatology, Marmara University School of Medicine, 34899 Istanbul, Turkey. burak.tekin@marmara.edu.tr. Atay Zeynep Z Ergun Tulin T Can Meryem M Tuney Davut (...) D Babay Sofia S Turan Serap S Bereket Abdullah A Zlotogorski Abraham A Molho-Pessach Vered V eng Case Reports Journal Article Sweden Acta Derm Venereol 0370310 0001-5555 0 Nucleoside Transport Proteins 0 SLC29A3 protein, human IM Adult Child Hearing Loss, Sensorineural genetics Histiocytes pathology Humans Hyperpigmentation genetics pathology Hypertrichosis genetics pathology Male Nucleoside Transport Proteins genetics Phenotype Syndrome 2015 5 28 6 0 2015 5 28 6 0 2016 8 16 6 0 ppublish

2015 Acta Dermato-Venereologica

77. Hirsutism

Hirsutism , HIRSUTISM , Excessive growth of hair , Excessive hair growth , Hairiness , hirsutism , excessive facial or body hair (symptom) , hirsutism (diagnosis) , excessive facial or body hair (hirsutism) , excessive facial or body hair , Hirsutism [Disease/Finding] , hypertrichosis , polytrichia , excessive hairiness , excessive growth hair , hairiness , excessive growth of hair , excessive hair growth , pilosis , hirsuitism , hirsute , Hirsuitism , Hirsutism (disorder) , Hirsuties , Pilosis (...) , Hirsutes , Hirsutism, NOS French HIRSUTISME , Pilosité , Hirsutisme Portuguese HIRSUTISMO , Pilosidade , Hirsutismo Spanish HIRSUTISMO , Vellosidad , crecimiento excesivo del pelo (trastorno) , crecimiento excesivo del pelo , pilosis , hirsutismo (trastorno) , hirsutismo , Hirsutismo German HIRSUTISMUS , Hirsuitismus , Behaartheit , Hirsutismus Dutch behaardheid , hirsutisme , Hirsutisme Italian Villosità , Pelosità anormale , Irsutismo Japanese 男性型多毛症 , ダンセイガタタモウショウ Swedish Hårighet, patologisk

2015 FP Notebook

78. Approach to the management of idiopathic hirsutism Full Text available with Trip Pro

Approach to the management of idiopathic hirsutism 22337742 2012 09 20 2018 11 13 1715-5258 58 2 2012 Feb Canadian family physician Medecin de famille canadien Can Fam Physician Approach to the management of idiopathic hirsutism. 173-7 Markovski Milena M Saskatoon Health Region, RxFiles Academic Detailing, c/o Saskatoon City Hospital, Saskatoon, Canada. Hall Jill J Jin Margaret M Laubscher Tessa T Regier Loren L eng Case Reports Journal Article Canada Can Fam Physician 0120300 0008-350X IM (...) Adult Diagnosis, Differential Female Hirsutism diagnosis etiology therapy Humans 2012 2 17 6 0 2012 2 18 6 0 2012 9 21 6 0 ppublish 22337742 58/2/173 PMC3279274 Saudi Med J. 2011 Jan;32(1):23-6 21212911 Cleve Clin J Med. 2010 Jun;77(6):388-98 20516250 Hum Reprod Update. 2012 Mar-Apr;18(2):146-70 22064667 Contraception. 2003 May;67(5):349-53 12742556 Cochrane Database Syst Rev. 2003;(4):CD001125 14583927 N Engl J Med. 2005 Dec 15;353(24):2578-88 16354894 Fertil Steril. 2006 Feb;85(2):436-40 16595223

2012 Canadian Family Physician

79. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism. (Abstract)

Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism. Hyperandrogenism refers to classical androgen-dependent signs such as hirsutism, acne and androgenetic alopecia. Hirsutism is the main hyperandrogenic symptom, defined as an excess of body hair in the androgen-sensitive skin regions of the women. In this review, we attempt to focus on the pathogenesis of hirsutism related to disorders other than polycystic ovary syndrome (PCOS). Also, we will discuss (...) their clinical and biochemical features as well as therapeutic options.Several original articles, meta-analysis and reviews have been screened in the field of hirsutism and hyperandrogenic disorders.Current English literature including our studies suggests that PCOS is the most common cause of hirsutism. The most important purpose for investigation is to identify those women with androgen-secreting tumours because of their life-threatening potential. In approximately 1-8% of the women with hirsutism

2012 European journal of clinical investigation

80. Altering hirsutism through ovulation induction in women with polycystic ovary syndrome. Full Text available with Trip Pro

Altering hirsutism through ovulation induction in women with polycystic ovary syndrome. Many women with polycystic ovary syndrome (PCOS) experience infertility and hirsutism and often seek treatment for both concurrently. We investigated whether women who ovulate in response to treatment with clomiphene citrate, metformin, or both would have greater improvement in hirsutism compared with those who did not ovulate.This is a secondary analysis evaluating the change in Ferriman-Gallwey score (...) for the hirsute women (n=505 [80.7%]) from the Pregnancy in Polycystic Ovary Syndrome I study. This was a prospective, randomized, doubled-blind trial of 626 women with PCOS and infertility recruited from 12 university sites. They were treated with clomiphene citrate, metformin, or both (combination) for up to six cycles, and hirsutism evaluators were blinded to group assignment.There was a significant decrease in the Ferriman-Gallwey score between baseline and completion of the study in each of the three

2012 Obstetrics and Gynecology Controlled trial quality: uncertain

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>